PYC Therapeutics LimitedASX: PYC

PKD Program - ASN Presentation

· Issued by PYC Therapeutics Limited via ASX

Filed with ASX ·

23 October 2026 POLYCYSTIC KIDNEY DISEASE PROGRAM – AMERICAN SOCIETY OF NEPHROLOGY PRESENTATION • PYC is a precision medicine company dedicated to changing the lives of patients with genetic diseases who have no treatment options available • The Company is progressing a drug candidate (known...

View Attachment

6ix hasn’t read this filing yet.

PYC Therapeutics Limited on 6ix

In the deck

Earlier from PYC Therapeutics

Later from PYC Therapeutics

All PYC Therapeutics news releases